Survival After Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma: A Meta-Analysis

Chen, Jinggui; Huang, Kai; Wu, Jianghong; Zhu, Huiyan; Shi, Yingqiang; Wang, Yanong; Zhao, Guijuan

doi:10.1007/s10620-010-1482-0

Cited by 63 publications

(52 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To the best of our knowledge, whether hepatectomy for HCC should be performed as an AR or a NAR still remains unclear, because no randomized controlled trials are currently available on this topic. A meta-analysis included nine retrospective studies indicating AR is associated with better disease-free survival than NAR (21). Another meta-regression included 18 observational studies also showed a similar result (22).…”

Section: Hepatic Resectionmentioning

confidence: 93%

Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection

Zhu

Huang

Liao

et al. 2016

Jpn. J. Clin. Oncol.

View full text Add to dashboard Cite

Hepatocellular carcinoma is the most common malignancy in liver, is also a global problem and is the fourth most commonly diagnosed cancers among men and the fourth leading causes of cancer death among both men and women in China. Liver resection or hepatic resection and radiofrequency ablation is widely accepted as a first-line surgical approach for hepatocellular carcinoma in China. However, the indications of radiofrequency ablation or hepatic resection are different and not unified in China. In this article, we review the current status of hepatic resection and radiofrequency ablation therapies in hepatocellular carcinoma management in China.

show abstract

Section: Hepatic Resectionmentioning

confidence: 93%

Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection

Zhu

Huang

Liao

et al. 2016

Jpn. J. Clin. Oncol.

View full text Add to dashboard Cite

show abstract

“…Meanwhile, there is strong evidence that anatomic resection is superior to non-anatomic, i.e., atypical resection for HCC. As evaluated by several meta-analyses, anatomic resection is associated with improved survival rates, and delayed intrahepatic and systemic disease-recurrence with no differences regarding perioperative morbidity or mortality [100][101][102] . Interestingly, one recently published meta-analysis by Tang et al [103] could not demonstrate superiority of anatomic resection, but this seems to be explainable by the different trial selection compared to previous analyses.…”

Section: Anatomic Vs Atypical Resectionmentioning

confidence: 99%

Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives

Slotta

Kollmar

Ellenrieder

et al. 2015

WJH

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is the most common liver-derived malignancy with a high fatality rate. Risk factors for the development of HCC have been identified and are clearly described. However, due to the lack of tumor-specific symptoms, HCC are diagnosed at progressed tumor stages in most patients, and thus curative therapeutic options are limited. The focus of this review is on surgical therapeutic options which can be offered to patients with HCC with special regard to recent findings, not exclusively focused on surgical therapy, but also to other treatment modalities. Further, potential promising future perspectives for the treatment of HCC are discussed. EPIDEMIOLOGYHepatocellular carcinoma (HCC) is a very common malignant disease with more than 700000 new patients diagnosed per year. Interestingly, the incidence of HCC varies relevantly throughout the world. Whereas HCC is a very common malignant disease in sub-Saharan Africa, and central and south-east Asia with incidence rates of 20-47/100000 habitants, the incidence of REVIEW Submit a

show abstract

“…Two recent meta-analyses of observational studies have also reported conflicting results (30,31). Importantly, underlying cirrhosis was significantly more common in patients who underwent NAR and who also displayed greater hepatic dysfunction compared to patients who underwent AR.…”

Section: Anatomical Vs Non-anatomical Resectionmentioning

confidence: 99%

Recent advances in surgical treatment of hepatocellular carcinoma

Song

2015

DD&T

View full text Add to dashboard Cite

Survival After Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma: A Meta-Analysis

Abstract: Anatomic resection is associated with better disease-free survival than nonanatomic resection. Because heterogeneity was detected, caution is needed in interpretation of the results. Better designed, adequately powered studies are required to address this issue.

Cited by 63 publications

References 34 publications

Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection

Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection

Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives

Recent advances in surgical treatment of hepatocellular carcinoma

Contact Info

Product

Resources

About